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Natural Killer (NK) cells have been implicated in the response to poxviruses, but the interaction between NK and infected cells is not well
characterized. We show that downregulation of class I major histocompatibility complex (MHC-I) molecules in human cells by vaccinia virus
(VV) sensitizes the cells to lysis by NK cells. We provide evidence suggesting that NK cells are infected as a consequence of co-culture with
infected target cells. We also show that infection of NK cells leads to a marked depression of cytotoxicity. Moreover, the effect on NK cytotoxicity
occurs within hours of infection and is prevented by UV inactivation of the virus but is only partially prevented by blocking late gene expression.
VV infection also renders the NK cells more sensitive to inhibitory signals. Together our observations suggest that VV infection of NK cells can
modulate their signaling in a manner that prevents them from acting on infected target cells.
D 2005 Elsevier Inc. All rights reserved.Keywords: Natural killer cell; Vaccinia virus; ImmunomodulationIntroduction
Tremendous insight into mechanisms of immune-evasion
has been gained through studying vaccinia virus (VV). VV is a
member of the orthopox genera of poxviruses. Poxviruses are
large, enveloped, double-stranded DNA viruses that replicate
entirely in the cytoplasm of host cells. Poxviral genomes
generally encode upwards of 200 genes, roughly half of which
are devoted to evading the host immune response. Immune
evasion strategies encoded by poxviruses include proteins that
interfere with aspects of the both the innate and adaptive
immune response (reviewed in Seet et al., 2003). Poxviruses
block complement, cytokines, chemokines, as well as prevent
apoptosis, antigen presentation and other intracellular signaling
processes. Typically poxvirus infection occurs through expo-
sure at the cutaneous layer or through mucus membranes
(reviewed in Buller and Palumbo, 1991). At these barriers,
various innate leukocytes such as dendritic cells and natural
killer (NK) cells provide a first line of defense against invading0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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1 These three authors contributed equally to this paper.pathogens. Therefore, NK cells are among the targets of
poxviruses to subvert the immune response.
NK cells are large granular lymphocytes known to
contribute to the early immune response to viruses (Biron,
1997; Long et al., 1997). NK cells possess innate cytolytic
activity and can be further stimulated by cytokines such as
IFN-a and h, IL-12 and IL-18 that are produced mainly by
dendritic cells in response to viral infection. NK cells are also
stimulated by direct interaction with dendritic cells and aid in
stimulation of dendritic cells to instigate an adaptive immune
response (Raulet, 2004). Importantly, NK cells directly
impede viral replication by lysis of infected cells through
release of cytolytic granules or engagement of Fas receptors,
as well as by secretion of antiviral cytokines such as IFN-g.
NK cells are triggered by activating receptors which initiate
intracellular signaling events through tyrosine kinases, ulti-
mately resulting in polarized degranulation and cytokine
secretion (Vivier et al., 2004). There are several different NK
activating receptors encoded within the natural cytotoxicity
receptor complex located within the NK gene complex
(reviewed in Moretta et al., 2001). There are NK activating
receptors that specifically recognize infected cells, that bind
to endogenous markers of cellular stress or bind to ligands
thought to be constitutively expressed on healthy cells. For06) 75 – 87
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hemagglutinins (Mandelboim et al., 2001), and the murine
activating receptor Ly49H binds to an MHC-I homologue
encoded by MCMV (Arase et al., 2002). However, NK cells
determine their response based on integration of positive and
negative stimuli they receive upon contact with potential
target cells. The negative regulation of NK cells is through
class I major histocompatibility complex (MHC-I) proteins,
which are targeted by many viruses and tumors in order to
evade T cell responses. To detect classical MHC-I molecules,
human NK cells express inhibitory receptors belonging to the
killer cell immunoglobulin-like receptor (KIR) family (Long,
1999). The cytoplasmic tail of KIRs contains immuno-
receptor tyrosine-based inhibitory motifs (ITIMs) that provide
the biochemical basis for inhibition through the recruitment
of a tyrosine phosphatase, SHP-1 (Burshtyn et al., 1996,
1999).
There are several lines of evidence that NK cells play an
important part in the defense against members of the
orthopoxvirus genera. The resistance of certain mouse strains
to ectromelia virus maps to the NK gene complex, containing
genes involved in activation and regulation of NK cell
responses (Delano and Brownstein, 1995). Furthermore,
depletion of NK cells with asialoGM1 renders mice more
susceptible to VV (Bukowski et al., 1983). VV is known to
moderately downregulate MHC-I (Baraz et al., 1999; Bosh-
kov et al., 1992; Brutkiewicz et al., 1992), but whether or not
the down regulation is sufficient to stimulate NK cells has not
been well established for either human or mouse cells. The
specific NK receptor responsible for VV recognition is
unknown, but human NK cells exhibit increased lysis of
VV-infected targets in vitro (Baraz et al., 1999). Ectromelia
virus encodes a protein p13 that antagonizes the function of
IL-18 and thus indirectly interferes with activation of NK
cells (Born et al., 2000). Homologues of ectromelia p13 are
encoded by VV, cowpox and molluscum contagiosum virus
(Novick et al., 1999; Smith et al., 2000). In addition, VV and
ectromelia also encode soluble IFN-g receptors that block the
action of IFN-g (Alcami and Smith, 1996a, 1996b). These
mechanisms serve to dampen the NK response indirectly
without preventing the constitutive activity of NK cells to
lyse target cells. In addition to the immune-evasion strategies
that rely on secreted proteins that modulate innate immunity,
VV can also directly infect several types of innate immune
cells including dendritic cells resulting in blocking dendritic
cell maturation into functional antigen presenting cells
(Engelmayer et al., 1999). Given that NK cells are among
the first cells recruited to a site of viral infection and do not
require activation by other cytokines to begin to lyse target
cells, NK cells are an obvious target for viruses to modulate
by direct infection. After encountering a potential target cell,
NK cells make intimate contact with the target cell and then
release their cytolytic granules. At a site of infection, NK
cells intimately contacting a VV-infected target cell are likely
exposed to VV possibly making them a target for VV
infection. We and others have used VV as a vector for protein
expression in NK cells indicating these cells are able to beinfected by VV (Burshtyn et al., 1996; Paolini et al., 1999;
Rajagopalan and Long, 2000; Ting et al., 1995; Wagtmann
et al., 1995; Wei et al., 2000); however, infection of NK cells
requires highly concentrated purified virus in the absence of
serum. Therefore, we questioned whether NK cells could be
infected in a more physiologic setting such as during contact
with productively infected cells.
Here, we show that VV infection decreases MHC-I
expression on target cells enough to prevent KIR-mediated
protection of the target cell. More interestingly, we provide
evidence suggesting that NK cells are subject to infection
themselves during contact with VV producing target cells. We
show that infection leads to a reduction in the cytolytic capacity
of the NK cells. The implication of these results is that VV may
modulate NK responses by infecting NK cells that enter the site
of infection to render them less sensitive to VV-infected target
cells.
Results
Downregulation of HLA-C by VV and KIR responses
To explore the possibility that downregulation of MHC-I
induced by members of the orthopoxvirus genera may be
sufficient to activate NK cells, we investigated if VV
infection affects surface expression of human MHC-I and if
the associated change was sufficient to influence KIR
signaling. First, MHC-I expression was monitored following
infection by flow cytometry using the pan reactive anti-HLA
antibody W6/32. We compared expression of total MHC-I on
the surface of HEK293T cells and Jurkat T cells, which
express a full complement of MHC-I genes, namely HLA-A,
B and C. As a positive control for a reduction in HLA
expression, we blocked new protein synthesis with cyclohex-
imide. The decreases in MHC-I expression after 8 h of
infection are shown in Fig. 1. NK cell recognition of target
cells is regulated to a major extent by KIR recognition of
HLA-C type molecules (Valiante et al., 1997); however, one
previous report suggested that VV downregulates MHC-I
expression but perhaps not HLA-C (Baraz et al., 1999).
Therefore, we examined downregulation of a subset of HLA-C
alleles each recognized by a KIR molecule, namely HLA-
Cw4, HLA-Cw7 and HLA-Cw15 that were each stably
expressed in the MHC-I-deficient B cell line, 721.221. We
observed comparable loss of all HLA-C alleles (Fig. 1C) after
VV infection. The loss of MHC-I expression following
infection suggested that VV-infected target cells should
become more sensitive to NK cells.
We next evaluated if our model NK line NK92 expressing
KIR could detect the loss of MHC-I following infection by
VV. NK92 and NK92 cells expressing KIR2DL3 cells were
used in a cytolysis assay with 221-Cw7 target cells that were
either mock infected or infected with VV (HLA-Cw7 is a
ligand for KIR2DL3). Parental NK92 cells lysed 221-Cw7
cells, and this lysis is not altered in the presence of an
antibody specific for KIR (Fig. 2A, panel i). Expression of
KIR2DL3 in NK92 cells inhibits lysis of 221-Cw7 cells, and
Fig. 1. Reduction of MHC-I surface expression following infection. (A) 293T cells were either untreated (dashed line), treated with cycloheximide (shaded) or
infected with VV-pSC66 at MOI of 10 (thick line) for 8 h. The cells were stained with anti-MHC-I antibody W6/32. Isotype matched control antibody is indicated by
the thin black line. (B) Jurkat cells and (C) 221-Cw4, 221-Cw7 and 221-Cw15 cells were treated as in panel A except they were infected at an MOI of 10 with VV-
WR. The bar graphs below each histogram indicate the percent residual cell surface MHC-I after infection (VV) or treatment with cycloheximide (CHX). The data
are representative of six independent experiments.
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DX27 (Fig. 2A, panel ii). Following infection of the target
cells, both NK92 and NK92-KIR2DL3 lyse the target cells
similarly in the presence and absence of the anti-KIR
antibody (Fig. 2A, panels iii and iv).
Next, we generated NK clones from two healthy NK donors
(see Materials and methods for details) and tested if these
KIR2DL1 positive clones could also detect the loss of MHC-I
following VV infection. We either mock infected or VV
infected 221-Cw15 target cells (HLA-Cw15 is a ligand for
KIR2DL1) and used these cells in a cytolysis assay with two
KIR2DL1 positive clones in the presence or absence of anti-
KIR blocking antibody HP-3E4 (Fig. 2B and data not shown).
Following infection of the target cells, the KIR2DL1 positive
NK clone is sensitive to the loss of MHC-I from the target
cells. These observations suggest that the decrease in MHC-I
following VV infection is sufficient to render infected cells
more sensitive to lysis by NK cells.
NK cell infection
To establish whether NK cells could be infected when
exposed to other cells infected with VV, we performed co-
culture experiments and compared infection to our estab-
lished protocols for infecting NK cells directly with purified
virus (Rajagopalan and Long, 2000). To facilitate these
experiments, we generated a recombinant VV strain WR that
expresses the enhanced green fluorescent protein (EGFP)
under the control of the synthetic early/late promoter and
monitored the infection of the target cells by flow cytometry.
We performed co-culture experiments with VV-EGFP
infected monolayers of TK-cells incubated with NK cells
on top of the infected monolayer. The amount of NK cellinfection was compared to direct infection of NK cells with
purified virus in the presence or absence of serum. Human
NK cells were exposed for 4 h to infected monolayers or
directly infected with purified VV-EGFP. After 4 h, the NK
cells were gently removed and processed for flow cytometry
using anti-LFA-1 antibody to distinguish NK cells from TK-
cells that may be included in the sample. Uninfected NK
cells (mock) are LFA-1 positive and GFP negative (Fig. 3A,
panels a–d). Over 50% of primary NK cells became EGFP
positive by exposure to the infected monolayer (Fig. 3A,
panel i). Importantly, the fraction of EGFP positive NK cells
did not change in the presence of serum (Fig. 3A, panels i
and k). This is in stark contrast to the NK cells infected
with the purified virus (Fig. 3A, panels e and g). To control
for non-specific transfer of EGFP to the NK cells, we
included cycloheximide during the co-culture or infection.
Cycloheximide prevented EGFP expression in NK cells
directly infected or infected by co-culture (Fig. 3A, panels f,
h, j and l). A quantitative depiction of the results with the
human NK population cells is shown in Fig. 3B. As well, in
similar experiments with NK92 cells, we observed that while
NK92 cells are also infected during co-culture, the infection
remains somewhat sensitive to the presence of serum (Fig.
3B). To ensure that the NK cells are actually infected as
opposed to simply having EGFP stuck to their external
surfaces, we ‘‘infected’’ fixed NK cells by direct infection or
performed co-culture with infected monolayers for 4 h. Fig.
3C demonstrates that fixed NK92 and human-derived NK
cells do not acquire EGFP. That we detected VV driven
EGFP expression in NK cells following contact with
infected target cells, especially in the presence of serum,
suggests that NK cells are potential targets for VV infection
in vivo.
Fig. 2. HLA-C-mediated protection of target cells is lost after infection with VV. (A) The target cell line 221-Cw7 was either mock infected or infected with VV-
pSC66 at an MOI of 10 for 14 h. The cells were then labeled with 51Cr and cell lysis determined by the 51Cr release assay. Cell lysis was determined in the presence
(open triangle) or absence (filled square) of 10 Ag/ml anti-KIR blocking antibody DX27. The data are representative of three independent experiments. (B) The target
cell line 221-Cw15 was either mock infected or infected with VV-pSC66 at an MOI of 10 for 12 h. The cells were then labeled with 51Cr and cell lysis determined by
the 51Cr release assay. Lysis by the KIR2DL1 positive human NK clone was determined in the presence of a 1/40 dilution of anti-KIR blocking ascites HP-3E4
(hatched bars) or control IgM antibody MOPC-104 (black bars). The data are representative of three independent experiments.
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VV is known for its ability to infect a broad range of cell
types, but infection of other innate immune cells such as
macrophages and dendritic cells is non-productive (Broder et
al., 1994; Engelmayer et al., 1999; Jenne et al., 2000; Natuk
and Holowczak, 1985). Therefore, we tested if VV WR
replicated in NK92 cells or IL-2 activated human NK cells. As
a positive control, the replication of the virus was measured in
TK-cells. The VV associated with the cell pellet was released
by 3 rounds of freeze/thaw and titered. Replication of VV in
TK-cells was clear following infection at an MOI of 1, but no
replication was detected for both the NK92 or primary NK
cells (Fig. 4A). However, by flow cytometry with the antibody
VV-1, we determined that only a small fraction of the NK
cells were infected after 4 h of VV infection at an MOI of 1
(data not shown). Therefore, we performed similar experi-ments at an MOI of 10 that achieves VV-1 staining in 90% of
the cells, but replication was not obvious under these
conditions either (Fig. 4A).
Late viral gene expression in NK cells
To determine if VV infection in NK cells progresses to the
point of late gene expression, we exploited the h-galactosidase
expressed by our recombinant VV. h-Galactosidase expression
in the pSC66 recombinant VV is driven by the p7.5 promoter
that is a natural early/late promoter of moderate strength
(Chakrabarti et al., 1997; Cochran et al., 1985). We first
assayed h-galactosidase activity using X-gal staining of the
cells. Blue color was obvious for the NK92 cells, but the
intensity of color in the primary NK cells was very faint.
Western blots confirmed that there was greater expression of h-
galactosidase in the NK92 cells compared to the primary NK
Fig. 3. Infection of NK cells by direct infection or co-culture with infected monolayers. (A) NK cells (human-derived population) were mock treated panels a–d,
directly infected with semi-pure VV-EGFP panels e–h or co-cultured with infected TK-monolayers panels i – l for 4 h (see Materials and methods for details). This
was carried out in the presence panels b, d, f, h, j, l or absence panels a, c, e, g, i, k of cycloheximide (CHX) or in the presence panels c, d, g, h, k, l or absence panels
a, b, e, f, i, j of 20% FBS serum. The non-adherent cells were recovered an analyzed for expression of LFA-1 (NK cell marker) and EGFP. The percentage in each
panel indicates the percent of EGFP positive infected NK cells. (B) The percent of infected NK cells (human-derived NK cells or NK92 cell line) by direct infection
or co-culture was calculated as the ratio of the number of EGFP and LFA-1 positive cells divided by the total number of LFA-1 positive cells multiplied by 100. The
data are representative of four independent experiments. (C) 1/20 formalin fixed or mock fixed NK92 and NK Population cells were infected for 4 h with VV-EGFP
at an MOI of 10 for direct infection or with VV-EGFP infected monolayers for co-culture infections and EGFP fluorescence determined by flow cytometry (FL-1).
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the primary NK cells showed weak expression of h-galacto-
sidase at 3 h (data not shown). However, for both types of cells,
treatment with Ara-C decreased the expression even at 3 h post-
infection (Fig. 4B). These results imply that some replication of
the viral DNA and concomitant expression of late genes occurs
in these cells although this appears to be quite minimal for the
primary NK cells. Therefore, while some late gene expressionoccurs, this does not lead to production of infectious virus,
even in NK92 cells.
VV infection modulates NK cell function
To assess the effect of VV infection on the function of NK
cells, we infected various primary IL-2 activated NK cells and
NK92 with purified VV for 2 h and then determined the ability
Fig. 5. NK cell cytolytic activity is inhibited by VV infection. (A) NK92 and
primary IL-2 activated NK cells (NK pop) were mock treated (black bar) o
infected with VV-pSC66 (dashed bar) at an MOI of 10 for 2 h. Cytolysis o
721.221 target cells was measured using a 51Chromium release assay at an
effector to target ratio of 25:1. (B) NK92 cells were mock infected or infected a
an MOI of 10 for 2 h with VV-pSC66 in the presence or absence of Ara-C
infected with UV-inactivated VV-pSC66, treated with cycloheximide (CHX) o
treated with CHX and VV-pSC66 infection in combination. Cytolysis o
721.221 target cells was measured by 51Cr release.
Fig. 4. Replication of VV virus and late gene expression in NK cells. (A) The
indicated cells were infected at the indicated MOI with VV-pSC66 and VV
replication determined at indicated time points by titration on TK-cell
monolayers. (B) Samples of NK92 and human-derived NK cells were infected
at an MOI of 10 and lysed in 1% Triton X-100 lysis buffer. Following SDS-
PAGE, the samples were Western blotted with anti-hgal antisera. Samples are
as follows: lane 1, mock infected; lane 2, 0 h; lanes 3 and 4, 3 h; lanes 5 and 6,
10 h; lanes 7 and 8, 24 h. The data are representative of at least three
independent experiments.
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assay (Fig. 5A). Infection reduced the effectiveness of both the
NK92 cells and the IL-2 activated NK cells at all effector to
target ratios examined, and this reduction was strengthened
with increased duration of infection (data not shown).
Exposure to UV-inactivated virus did not substantially affect
the level of lysis by the NK cells indicating that active virus
infection was necessary for NK cell inhibition of killing. To
assess the contribution of late gene expression in reducing
killing, we performed the assay in the presence of Ara-C
which prevents replication of the DNA and subsequent
production of late proteins (Fig. 5B). Ara-C partially restored
the ability of NK92 cells to lyse 721.221 cells that are devoid
of MHC-I. The results also suggest that while late genes might
be responsible for modulating the function of the NK cells,
events that occur early during infection also modulate NK
cytolytic activity. This is likely to be particularly true for the
primary NK cells that only produce low levels of late proteins.
To determine if any of the effect on NK cytotoxicity was an
indirect consequence of VV interference with host protein
synthesis, we blocked protein synthesis with cycloheximide.
Cycloheximide alone had no effect on NK92 (Fig. 5B) or
primary NK cell lysis (data not shown) of the target cells.
When we used the combination of cycloheximide and VV
where both viral and host protein synthesis are shut down, we
served an intermediate effect on the NK cytolytic activity.
Together, these results suggest that infection with active virus
is required to modulate NK cell cytotoxicity, and that both
early and late events are responsible for decreasing cytotoxi-
city initiated by NK cells.Infection renders NK92 cells more sensitive to inhibitory
receptors
We previously observed that KIR-mediated inhibitory
signals in NK92 cells appear more potent when KIR
expression is driven by recombinant VV than when KIR is
stably transfected into NK92 (Kirwan and Burshtyn, unpub-
lished observations). In view of our current findings that VV
decreases NK cytolytic function, we postulated that infection
with VV quickly tipped the balance of signaling towards
inhibition, perhaps by interfering with the activation-signal-
ing cascade. To test this hypothesis, we infected NK92 lines
stably transfected with KIR with a recombinant virus that
encodes h-galactosidase (VV-pSC66) and determined the
effects of VV infection on KIR signaling. We first examined
the effect of infection on signaling through KIR2DL3 when
encountering target cells bearing the MHC-I allele, HLA-
Cw7. The transfectant expresses relative low levels of KIR
and correspondingly results in a partial drop in lysis of
MHC-I bearing target cells (Fig. 6A). Following infection of
these cells with VV-pSC66 (in the presence of Ara-C), there
is a drop in cytotoxicity on both control cells and target cells
expressing MHC-I. However, the drop in lysis is much more
pronounced for the cells expressing the MHC-I (Fig. 6A),
suggesting that the infected NK cells are more sensitive to
inhibition through KIR. Notably, the short infection also didr
f
t
,
r
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Fig. 6. Inhibition through wild-type KIR2DL3 is increased following VV
infection of NK92 cells. (A) An NK92 line expressing low levels of KIR2DL3
was infected at an MOI of 15 with VV-pSC66 for 2 h. NK cell lysis was
measured by 51Cr release assay on both MHC negative targets 721.221 cells
and the MHC positive cells .221-Cw3. The effector to target ratio shown is
18:1. (B) A sample of the NK92-KIR2DL3 cells was stained with anti-KIR
antibody DX27 or VV-1 antibody and analyzed by flow cytometry. The thick
line represents the infected cells, the thin line the mock treated cells and the
dotted line represents background staining with secondary antibody only.
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while the cells are shown to be infected by VV-1 staining
(Fig. 6B).Fig. 7. Increased sensitivity to inhibitory signals requires active vaccinia virus.
(A) NK92 and NK92 cells expressing TR KIR-GFP were mock treated or
infected with VV-pSC66 at an MOI of 10 or UV-inactivated VV-pSC66 for 2 h.
The lysis of target cells expressing the MHC ligand (MHC + ve, .221-Cw15) or
without MHC (MHC  ve, 721.221) was measured at an effector to target cell
ratio of 15:1. (B) The flow cytometric analysis corresponding to panel A
showing the degree of infection of the NK92 and NK92 cells expressing TR
KIR-GFP by VV-1 staining on the mock-treated (thin grey line), VV-infected
(thick black line) or UV-VV infected (dashed line) cells.We utilized an even more sensitive readout by assessing the
very weak inhibitory signal provided by ITIM-deficient KIR
through the inhibitory co-receptor ILT2 (Kirwan and Burshtyn,
2005). These experiments were performed with a cell line
expressing a truncated KIR fused to EGFP, TR-KIR-EGFP
NK92 (Standeven et al., 2004). The weak inhibition through
KIR/ILT2 when engaged by MHC-I expression in 721.221
cells is barely detectable (Fig. 7), although it is detected with
target cells that express a higher density of ligand (Kirwan and
Burshtyn, 2005). Importantly, infection of these effector cells
reveals the MHC-I specific inhibition as there is sensitivity to
this fixed amount of inhibitory signal when the effector cells
are VV infected (Fig. 7). In addition, we tested if the increased
sensitivity to inhibitory receptor signaling required active virus
by comparing the effect of active and UV-inactivated virus.
The UV-inactivated virus had no effect on signaling through
the KIR-ILT2 pathway (Fig. 7A). Again, since the threshold forFig. 8. Increased sensitivity to inhibitory signals provided by VV infection does
not occur by blocking protein synthesis. (A) Comparison of protein synthesis
inhibitors and VV infection on protein synthesis in NK92 cells. The cells were
treated as indicated below for 2 h and were labeled with 35S-methionine (see
Materials and methods). Samples were analyzed by SDS-PAGE and autoradio-
graphy to determine the block on protein synthesis. Samples are as follows: lane
1, mock infected; lane 2, 100 Ag/ml cycloheximide; lane 3, 5 Ag/ml emetine;
lane 4, 25 Ag/ml emetine; lane 5, MOI of 15 VV-pSC66; and lane 6, MOI of 15
VV-pSC66 with Ara-C. (B) NK92 cells or NK92 cells expressing TR KIR-GFP
were pre-treated with emetine (EMT). Cytolysis was measured at an E:T ratio of
5:1. The black bars are 221-Cw3 which express an irrelevant MHC-I protein,
and the hatched bars are 221-Cw15 target cells expressing the KIR ligand. (C)
Corresponding flow cytometric analysis for the NK92 cells used in panel B to
show the levels of KIR do not change. NK92 and NK92 expressing TR KIR-
GFP cells appear left to right, with emetine treated (thick black line) or mock
treated (thin grey line).
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host proteins, we tested if the effect of infection on KIR
signaling could be mimicked by a block in protein synthesis
using the protein synthesis inhibitor emetine. While pre-
treatment of the NK92 cells with emetine clearly reduced
synthesis of cellular proteins as did virus infection (Fig. 8A), it
did not augment the amount of inhibition observed by the KIR-
ILT2 pathway (Fig. 8B). These results suggest factors rapidly
introduced by infection are responsible for increasing the
sensitivity of NK cells to inhibition by inhibitory receptors.
Discussion
The loss of MHC-I expression from the cell surface
following viral infection helps viruses evade cytotoxic T cells
but renders them susceptible to NK cells. It has previously been
shown that the window of vulnerability of VV-infected mouse
cells to NK cell-mediated cytolysis is concomitant with a
decrease in mouse MHC-I expression (Brutkiewicz et al.,
1992). The results presented here support a role for MHC-I loss
in sensitizing VV-infected human cells to NK cells. Similar to
what has been previously reported in primary human T cells
(Baraz et al., 1999), we observed MHC-I loss on HEK293 and
Jurkat cells that presumably have a full complement of MHC-I
molecules, HLA-A, B and C. The downregulation of HLA-C is
pertinent because HLA-C is one of the major ligands for KIR,
and in many individuals, a large fraction of their NK cells are
regulated through HLA-C. We also observed a decrease of
MHC-I expression for 221-Cw4, Cw7 and 221-Cw15 cells that
only express HLA-C. Our results differ from those of Baraz et
al. as they did not observe a loss of HLA-Cw3 from 221-Cw3
cells even 24 h after infection (Baraz et al., 1999). Differences in
our approaches may lead to different rates of infection that
explain the discrepancy. Baraz et al. examined the cells 24
h after infection, a time at which we find most infected 721.221
cells are dead. To achieve near complete infection of the
721.221 derived cells, we used a higher dose of virus,
performed the infection in serum-free conditions and estab-
lished the majority of the cells were infected by flow cytometry
using an antibody to a viral protein. MHC-I downregulation has
been studied in depth for another poxvirus family member,
myxoma, that downregulates MHC-I from the cell surface
rapidly and very efficiently using the myxoma virus leukemia-
associated protein, MV-LAP/M153R (Boshkov et al., 1992;
Guerin et al., 2002) which has homologues in herpesviruses and
other poxviruses. However, VV does not contain a MV-LAP
homologue, and therefore, whether or not VV possesses specific
mechanisms to decrease MHC-I remains to be determined.
MHC-I loss from the cell surface may simply be due to the well-
described ability for VV to prevent transcription of host genes.
Even though the MHC-I decrease induced by VV is
relatively moderate, the loss of MHC-I, and more specifically
HLA-C, following VV infection may be important for
sensitizing VV-infected cells to lysis by NK cells (Fig. 2A).
We have provided evidence to support this by showing that the
loss of HLA-Cw7 after 14 h of VV infection is sufficient to
abrogate signaling via KIR2DL3 in NK92 cells. We have alsoshown that after a 12-h VV infection of HLA-Cw15 target
cells, human-derived KIR2DL1 positive NK clones are
sensitive to the loss of HLA-C from infected target cells
(Fig. 2B). It should be noted that the latter experiment tests
endogenous levels of high affinity KIR with a target cell line
expressing very high levels of HLA-C (Fig. 1C). A number of
different strategies used by viruses to evade NK cells have been
the topic of a recent review (Lodoen and Lanier, 2005). Viruses
that establish persistent infections often display potent MHC-I
downregulation and concomitant strategies to evade attack by
NK cells including decoy MHC-I-like proteins. However, there
are examples of MHC-I homologues in various poxviruses
such as molluscum contagiosum, swinepox virus and yaba-like
disease virus that do not establish a persistent infection
(Johnston and McFadden, 2003; Senkevich and Moss, 1998).
However, no such molecules have been reported to date for VV
or variola virus. These viruses possess alternative strategies to
evade NK cells in addition to blocking factors such as IFN and
IL-18 that serve to promote NK responses. Our results also
suggest that despite the anti-apoptotic proteins encoded by VV
strain WR that interfere with Granzyme B-mediated cell death
(Dobbelstein and Shenk, 1996; Kettle et al., 1997; Wasilenko
et al., 2003), the infected cells remain susceptible to NK-
mediated lysis. The ability of NK cells to lyse VV infected cells
may be due to the high levels of perforin secreted by these cells
that may induce membrane damage directly or release of
Granzyme M, a Granzyme that is highly expressed in NK cells
including NK92 and not conventional T cells (Krenacs et al.,
2003). Granzyme M does not rely on the typical caspase
cascade to induce cell death (Kelly et al., 2004). A more
detailed time course analysis of when and to what degree the
target cells are susceptible to NK cells might be very interesting
if, for example, the target cells are resistant until infectious
intracellular mature virions (IMV) accumulate.
Our results suggest that NK cells are readily infected
when they contact a monolayer of infected cells. It is
interesting that we consistently observed higher rates of
infection as measured by EGFP expression during co-culture
of primary NK cells compared to the transformed line NK92.
The reason for this difference is unknown but might be due
to differences in how these cells interact with the infected
cells, expression of receptors required for viral uptake or
inactivation of viral particles/genomes once inside the cells.
The ability of VV to infect NK cells could simply provide
another niche for viral replication. However, despite the
ability of purified virus to infect NK cells and evidence for
some progression to the late phase of infection, we did not
detect significant replication of VV in NK cells. One
complication of performing these experiments is the possi-
bility that once they are infected, the NK cells become victim
to other NK cells in the culture. However, we did not
observe viral replication even at high doses (MOI of 10) that
quickly render the NK cells unable to efficiently kill target
cells. Although replication in human NK cells cannot
completely be ruled out, it seems unlikely to be significant
based on our findings. The lack of replication of VV in NK
cells is similar to that observed for other cells that are part of
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dendritic cells is abortive, expression of late proteins is
difficult to detect and is accompanied by apoptosis (Broder
et al., 1994; Engelmayer et al., 1999; Jenne et al., 2000; Natuk
and Holowczak, 1985). There are only a few other examples
of viruses known to replicate in NK cells, such as HHV-6
and HIV (Chehimi et al., 1991; Lusso et al., 1993).
However, non-productive infection of cells of the immune
system can be adventitious for a virus if the infection
disrupts the immune response.
In this study, we show that infection of NK cells has
serious consequences for the cytolytic function of the NK
cells. The large loss in NK cytotoxicity that occurs within
hours of infection with VV is a result of infection. While the
precise mechanism by which VV affects the function of NK
cells remains to be determined, we determined that both
early and late gene products likely independently produce
effects on NK cells’ function because blocking late gene
expression only partially restores the function of the NK
cells. It is interesting that the combination of cycloheximide
with VV infection restores the function of NK cells to a
greater extent than Ara-C alone but not completely, suggest-
ing that new VV protein synthesis may not be required for
all of the consequences on the NK cell. When VV infects a
cell, there are a number of virion associated proteins that are
delivered into the cell. One candidate protein that may be
affecting NK cytolysis is the dual-specific phosphatase VH1
that enters the cell with the virion (Liu et al., 1995). VH1
has been shown to disrupt signaling cascades in a variety of
cell types (Alonso et al., 2003; Liu et al., 1995; Najarro
et al., 2001). A role of VH1 in decreasing signaling could
explain why UV inactivated virus has less of an effect than
cycloheximide, as UV treatment blocks VH1 release from
the virions (Najarro et al., 2001). Coincidentally, new
production of VH1 occurs late and could be blocked by
Ara-C as well.
It is perhaps not surprising that NK functions such as target
cell recognition, signaling and degranulation are disrupted by
the infection with VV. As the infection progresses, much of the
cellular machinery required for these functions such as the actin
and microtubule cytoskeleton are taken over by the virus, and
the morphology of cell is drastically altered. However, as many
early genes are associated with immune-evasion, the mecha-
nism by which early proteins dampen NK cytotoxicity may
represent a more deliberate strategy of the virus to impede the
function of NK cells.
The balance of the strength of the activating and inhibitory
signals an NK cell receives determines if a potential target
cell will be lysed or not. To maximize the sensitivity of NK
cells to losses in MHC-I expression, the ideal KIR-MHC-I
interaction would be just enough to prevent NK activation. In
fact, the benefit of a low threshold for NK activation was
recently implicated by the linkage of HCV resistance to
individuals that express a KIR with relative low affinity for
HLA-C (Freeman et al., 2005; Khakoo et al., 2004). In
relation to poxviruses, NK cells are likely most important to
control viremia during the window following infection priorto formation of new virus, as lysis at later time points might
simply facilitate viral dissemination. Using an NK cell line
transfected with an inhibitory receptor specific for HLA-C
(KIR2DL3) and NK clones, we observed that the early block
of cytolysis after VV infection of NK cells also manifests as
an enhanced inhibitory signal in response to HLA-C. These
observations suggest that infection of NK cells provides a
mechanism for the virus to rapidly block the function of NK
cells by a process that includes sensitizing the NK cells to
lower levels of class I molecules. The most likely scenario is
that viral proteins antagonize the activation-signaling cascade
which enhances sensitivity to KIR, as opposed to modifying
the KIR signal itself. The physiologic importance of VV
infection of human NK cells is understandably difficult to
assess. However, it is interesting that the highly attenuated
MVA strain (host restricted modified vaccinia virus Ankara)
shows a reduction in infectivity of NK and B cells, but not
monocytes, as the loss of NK infectivity could contribute to
MVA attenuation (Sanchez-Puig et al., 2004). There are
other examples of viruses infecting NK cells such as EBV
(Isobe et al., 2004), HIV (Chehimi et al., 1991) and HHV-6
(Lusso et al., 1993), but to our knowledge, this is the first
example of NK function being so dramatically affected by
infection so quickly. Given that NK cells are exposed when
they interact with virus producing target cells, it is likely that
NK cells that enter a site of infection are inactivated by this
process.
Materials and methods
Antibodies and inhibitors
Monoclonal antibodies DX27 specific for KIR2DL3
(IgG2a, DNAX), W6/32 a pan-HLA Ab (IgG2a, ATCC HB-
95), anti-LFA-1 alpha (IgG1, ATCC HB-202) and anti-CD8
51.1 (IgG2a, HB230 ATCC) were purified from culture
supernatants using protein A or G sepharose. The antibodies
were dialyzed into phosphate-buffered saline (PBS) and filter
sterilized for use in functional assays. Monoclonal antibody
EB6 specific for KIR2DL1/S1 (IgG1) was purchased from
Beckman Coulter Immunotech (Mississauga, Canada). Anti-
CD158a clone HP-3E4 (IgM) ascites was provided by Dr. E.
Long (Melero et al., 1994). Clarified MOPC-104E ascites
(control IgM) was purchased from Sigma-Aldrich. The
antibody VV-1-1G10-1-1 (VV-1), specific for VV A33R, was
a gift from Dr. Schmaljohn (Fort Dietrick, MD) (Hooper et al.,
2000). FITC- and PE-conjugated goat anti-mouse IgG were
purchased from Cedarlane (Hornby, Canada). Rabbit polyclon-
al ab616 anti-h-galactosidase antibody (IgG) was purchased
from abcam (Cambridge MA).
Cycloheximide (ICN Biomedicals) was dissolved in H2O,
used at a final concentration of 100 Ag/ml and maintained
throughout the experiments. Emetine-HCl (EMT, Sigma
Chemical Company) was dissolved in Iscoves medium and
used at a final concentration of 5 Ag/ml for 2 h and then washed
out. Cells were fixed in 2% formaldehyde (Sigma Chemical
Company) in PBS for 20 min at room temperature.
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The NK92 cells, a non-Hodgkin’s lymphoma line devoid
of KIR or Fc receptors, were obtained from ATCC (CRL-
2407) (Gong et al., 1994). NK92 cells were cultured in either
Iscoves medium containing 50% Myelocult H5100 (Stem
Cell Technologies) and 7.5% Fetal Bovine Serum (FBS)
(Hyclone) or aMEM medium with 12.5% FBS and 12.5%
horse serum (Invitrogen), supplemented with 25 AM 2-
mercaptoethanol and 1 mM l-glutamine (Invitrogen) and
100 U/ml human recombinant IL-2 (TECIN, obtained from
the Biological Resources Branch, DCTC, NCI-Frederick
Cancer Research and Development Center). NK92 cells
stably expressing various KIR molecules were cultured in
the same medium with the addition of 0.5 mg/ml geneticin
(Invitrogen). NK92 expressing the truncated KIR2DL1-EGFP
chimera (TR KIR-GFP) have been previously described
(Standeven et al., 2004). The cDNA encoding KIR2DL3
was subcloned using the restriction enzymes Xho I and Xba I
into the plasmid BSRaEN (provided by Kevin Kane,
University of Alberta). NK92 cells were electroporated, as
previously described (Standeven et al., 2004). Geneticin
resistant lines were propagated, screened for expression by
flow cytometry and subcloned to establish lines with stable
levels of expression.
The collection of blood and related experimentation was
approved by the Health Research Ethics Board at the
University of Alberta. Primary human NK cells were isolated
from whole blood by magnetic separation using StemSep
(Stem Cell Technologies). Isolated NK cells (both NK
population and NK clones plated at one NK cell per well)
were grown on irradiated 721.221 feeder cells in the presence
of 200 U/ml IL-2 and were maintained in culture for up to 6
weeks.
The MHC-I negative transformed B cell line 721.221 cells
were maintained in Iscoves medium with 10% FBS (Invitro-
gen) and 2 mM l-glutamine. The 721.221 transfected cell
lines 221-Cw3, 221-Cw4, 221-Cw7 and 221-Cw15 cells were
obtained from Peter Parham (Stanford University) and main-
tained in 0.5 mg/ml geneticin. HEK293T cells were grown in
DMEM medium (Invitrogen), 10% FBS, 10 mM HEPES
(Fisher) and 2 mM l-glutamine. Jurkat T cells were grown in
RPMI medium supplemented with 10% FBS, 25 AM 2-ME, 2
mM l-glutamine. Thymidine kinase-deficient human osteo-
sarcoma cell line 143B (ATCC #8303), herein referred to as
TK-cells, was grown in DMEM, 10% FBS, 10 mM HEPES
and 2 mM l-glutamine.
Recombinant vaccinia viruses and infection
Enhanced green fluorescent protein (EGFP) was sub-
cloned into the plasmid pSC66 using the sites Sal I and Not
I and recombined into the TK locus of VV WR as
previously described to generate VV-EGFP (Mackett et al.,
1984). VV strain WR, VV-pSC66 (Kirwan and Burshtyn,
2005) or VV-EGFP was purified on sucrose gradients or
semi-purified. Briefly, for semi-purification, the virus wasamplified in TK-cells, released from the cells by sonication
and enriched by spinning through a 36% sucrose cushion.
The titers of plaque-forming units/ml (PFU/ml) were
determined on TK-cells.
NK92 or primary NK cells were washed twice in Iscoves
medium supplemented with 2 mM l-glutamine, 0.1 mM non-
essential amino acids (Invitrogen), 0.2% Bovine Serum
Albumin (Boehringer Mannheim) and 100 U/ml rIL-2 (herein
referred to as NK infection medium). Generally, 5  105 to
4  106 NK cells were resuspended in NK infection media
(between 150 and 350 Al) and infected at the indicated
multiplicity of infection (MOI) with purified VV for 2 h at
37 -C with 5% CO2. The cells were washed once with assay
medium (5% FBS/Iscoves/2 mM l-glutamine/10 Ag/ml genta-
micin), counted and diluted for plating in the cytolysis assays.
Where indicated, experiments were carried out in the presence
of cytosine h-d-arabinofuranoside-HCl (Ara-C) (Sigma Chem-
ical Company) at a final concentration of 40 Ag/ml. When
necessary, VV was UV inactivated for 1 min with a UV
Stratalinker 2400 (Stratagene) or under a laminar flow hood
UV-lamp for 45 min. For the infection of fixed NK cells, NK92
or human-derived NK cells were fixed in 2% formaldehyde for
20 min, then washed into NK infection media and infected at
an MOI of 10 for 4 h with VV-EGFP. Infected NK cells were
quantified by flow cytometry based on EGFP.
For MHC-I downregulation experiments, 1  106 293T/17
cells were plated in 35-mm dishes in complete medium.
Eighteen hours later, the cells were washed with infection
medium and either treated with 100 Ag/ml cycloheximide or
infected at an MOI of 10 with VV-pSC66 for 2 h and switched
to complete medium. At 8 h, the cells were harvested with
PBS/1 mM EDTA. Infection was quantified by X-gal staining.
MHC-I expression was determined by flow cytometry using
the antibody W6/32 followed by PE-goat anti-mouse IgG.
Jurkat and 721.221 transfectants (5  105 cells in 0.1 ml) were
infected at an MOI of 10 with VV-WR virus in the same
manner as the NK cells for 1 h and then supplemented with
complete medium for the remaining 7 h. The sample was
washed and divided into two and stained with either VV-1 or
W6/32 followed by PE-goat anti-mouse IgG. Analysis of the
expression of surface proteins was performed by flow
cytometry.
Cytolysis assays
Target cells (0.5–1  106) were labeled with ¨10 ACi 51Cr
(Sodium Chromate, NEN) for 1 h at 37 -C in 5% CO2. The
targets were washed, diluted in assay medium and plated at
2500 cells per well in V-bottom microtiter plates in triplicate.
The NK effector cells were pretreated (as indicated in the figure
legends), washed once, counted and diluted to the appropriate
concentrations in assay medium with 100 U/ml rIL-2. For
antibody blocking experiments, NK cells were pre-incubated in
twice the final concentration of antibody for at least 10 min at
room temperature. Assays were incubated at 37 -C in 5% CO2
for 4 h. The released chromium was quantified for 50 Al of
supernatant and analyzed in a 1450 Microbeta Trilux (Wallac).
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release  mean spontaneous release)/(mean total release 
mean spontaneous release). The error bars represent the
standard deviation of the mean for each triplicate.
Infection of NK cells by co-culture with infected monolayers
TK-cells were plated at 5  105 cells in a 35-mm dish
for 22 h and then infected with VV-EGFP at a MOI of 3,
and incubated for 16 h before addition of NK cells. NK92,
primary NK cells, or formaldehyde fixed NK cells were
washed twice in NK infection medium and resuspended at
1  106 cells/ml. 1  106 NK cells were overlayed onto the
infected TK-cells in NK infection medium and cultured for
4 h. As a positive control, NK92 and primary NK
populations were infected with semi-pure EGFP-VV with
the same treatments. All cells were harvested with 2 washes
of PBS/1 mM EDTA and resuspended in FACS buffer (PBS/
1% FBS/1 mM EDTA). The cells were stained with anti-
LFA-1 and PE-coupled secondary antibody. The percent of
infected NK cells was quantified by flow cytometry based
on EGFP and LFA-1 markers.
Replication of VV and b-gal expression in NK cells
NK92 and human-derived NK cells were washed twice
with NK infection medium and resuspended in NK cell
infection medium at 5  106 cells/ml. For each point, 5  105
NK cells were infected in suspension at the indicated MOI.
TK-cells were plated at 5  105 cells in a 35-mm dish for 20
h and then infected with VV-pSC66 at a MOI of 1. At time 0
or after 1 h of infection, the NK cells were washed once in
PBS/1 mM EDTA, the appropriate complete medium was
added, and the NK cell samples were then grown in
suspension. The TK-cells were cultured in the 35-mm dishes,
and cells were scraped off at indicated time points, and the
wells were washed with PBS/1 mM EDTA. The infection was
terminated by pelleting the cells, resuspending in 1.2 ml of
DMEM medium with 2% FBS and frozen at 80 -C. When
all samples were collected, the virus was released by 3 rounds
of freezing and thawing and sonication. The samples were
titered on TK-monolayers.
For h-gal expression, NK cells were infected as above, and
at the indicated time points, the cells were lysed in 100 Al 1%
Triton-X100. Samples were run out on 8% SDS-PAGE,
transferred to Immobilon-P transfer membranes (Millipore)
and probed for h-galactosidase with ab616 antibody.
Metabolic labeling
NK92 cells were washed twice in infection medium,
followed by washing in methionine free DMEM medium
(Invitrogen). The cells were then treated with indicated amount
of cycloheximide or emetine or infected with VV-pSC66 for
2 h at 37 -C. After 2 h, the cells were incubated with 150 ACi
35S-methionine (ICN Biomed) for 15 min, washed with cold
PBS and lysed in lysis buffer (1% Triton w/v, 0.15 M NaCl, 20mM Tris pH 8) containing Complete protease inhibitor
cocktail (Roche). Nuclei and cell debris were removed by
centrifugation at (20,000  g) for 15 min at 4 -C. Samples
were separated by SDS-PAGE under reducing conditions and
the labeled proteins detected by autoradiography.
Note added in proof
It has come to our attention that emetine is reversible under
certain conditions and that 4 h post emetine treatment NK92
cells they synthesize protein at levels similar to untreated cells
(J. Smiley & G. Zahariadis, personal communication). There-
fore, the results in Fig. 8 depict a complete block of protein
synthesis for the 2 h pretreatment and questionable block
during the cytolysis assay itself.
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